CanImGuide Therapeutics AB - Company Review
SummaryCanImGuide Therapeutics AB - Company Review
Summary
Canimguide Therapeutics AB (CanImGuide) is a healthcare products provider that develops cancer therapies. The company develops therapies based on the discovery of immune regulatory substances. Its product includes proprietary drug P28R, a peptide with two modes of actions. CanImGuide's P28R has a direct immune stimulatory activity that is used to inhibit the task of an immune suppressor produced in malignant tumours. The company's P28R unblocks the immune suppressor molecule. It also carries research work to identify new cancer related immune regulatory structures. The company operates through laboratories located in Sweden, Germany and Denmark. CanImGuide is headquartered in Malmo, Sweden.
This comprehensive company report of CanImGuide Therapeutics AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.